QualityStocks would like to highlight Imprimis Pharmaceuticals, Inc. (OTCQB: IMMY), a specialty pharmaceutical company focused on the development and commercialization of non-invasive topically delivered medications. The company's innovative patented Accudel cream formulation technology is designed to enable highly targeted site specific treatment. Impracor, the company's lead pain product candidate, utilizes the Accudel platform technology to deliver the active drug ketoprofen, a non-steroidal anti-inflammatory drug, through the skin directly into the underlying tissues where the drug exerts its localized anti-inflammatory and analgesic effects.
In the company’s news last week,
Imprimis announced a strategic investment and development agreement with Professional Compounding Centers of America (PCCA). This company provides a variety of products and services to its member compounding pharmacies and works directly with prescribers to provide patients with specialized medications that are normally not available over-the-counter or by prescription. It has also led in the research and development of topical and transdermal technology, including its Lipoderm family of topical bases – the industry’s only bases proven to deliver four drugs at once.
The proposed agreement will allow the two companies to develop and share drug formulation technology with the goal of creating a new generation of treatments for muscle and joint pain, neuropathic pain, and other conditions. PCCA also made a $4 million equity investment into Imprimis. The agreement gives Imprimis exclusive non-PCCA-member access to PCCA’s topical technologies and formulation know-how for delivering drugs directly through the skin.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
